Regeneron Blows Away Q2 Estimates: $14.29 EPS and $4.29B Revenue

Posted on by http://wealthcreation.club
‼️ BREAKING: Regeneron Pharma (NASDAQ: REGN) reported second quarter EPS of $14.29, $3.71 better than the analyst estimate of $10.58. Revenue for the quarter came in at $4.29B versus the consensus estimate of $3.8B.
Unknown's avatar

Published by http://wealthcreation.club

http://wealthcreation.club—We are educating regular people about how to be able to make more money in a disciplined way

Leave a comment